Trademark: 97414087
Word
CIGNA PATHWELL BONE & JOINT
Status Date
Tuesday, October 17, 2023
Registration Number
7197678
Registration Date
Tuesday, October 17, 2023
Filing Date
Tuesday, May 17, 2022
Published for Opposition
Tuesday, January 3, 2023
36 Pharmacy benefit management services; pharmacy benefit management consulting services for those with musculoskeletal conditions; medical benefit management services concerning insurance for those with musculoskeletal conditions; advisory services and consultancy regarding medical insurance healthcare benefits, in-network coverage, and pharmacy benefits; provision of information and analysis in the fields of healthcare insurance plan benefits and pharmacy benefits for those with musculoskeletal conditions; prescription health care benefit coverage plans services, namely, providing insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries with musculoskeletal conditions; administration of pharmacy benefit plans concerning insurance; pharmacy benefit management services concerning insurance, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine musculoskeletal patients' future prescription drug and healthcare habits, all to identify clinical benefits for those with musculoskeletal conditions; prescription drug healthcare benefit plan services, namely, providing information to patients regarding in-network services in the field of complex musculoskeletal case management programs
35 Cost management for the healthcare benefit and prescription drug benefit plans of individuals with musculoskeletal conditions; business services, namely, pharmaceutical cost management services and drug utilization review services for the prescription drug and medical formulary plans of others with musculoskeletal conditions; consulting services regarding healthcare costs management and retail pharmacy services for those with musculoskeletal conditions; Drug utilization review services and drug and medical formulary cost management services for those with musculoskeletal conditions; pharmaceutical and medical cost management services and drug utilization review services for those musculoskeletal conditions; in-network provider advisory services and consultancy services, strategic business analysis and business advice in the field of medical insurance regarding pharmacy benefit management, and medical benefit management; business data analysis regarding health care benefit plan pharmaceutical end-user behavior, and health care benefit plan healthcare use behavior in the field of musculoskeletal conditions; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level for musculoskeletal conditions,; providing business intelligence services in the field of pharmacy benefit management; administration of employee benefit plans concerning pharmacy benefit plans for musculoskeletal patients; cost management for pharmacy health care benefit services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine musculoskeletal patients' future prescription drug and healthcare habits to identify potential cost savings for those with musculoskeletal conditions
44 Advisory services and consultancy regarding musculoskeletal healthcare; healthcare services, namely, wellness and disease management programs for musculoskeletal patients; health care services, namely, musculoskeletal disease management programs and complex musculoskeletal case management services in the nature of providing health consultation services to patients regarding medication compliance and providing healthcare and medical information regarding health and safety issues; providing medical information and analysis in the fields of musculoskeletal healthcare, and pharmaceuticals; providing information in the field of musculoskeletal healthcare to pharmacy benefit management clients, consultants and brokers
CIGNA PATH WELL BONE AND JOINT
"BONE & JOINT"
Oct 17, 2023
Notice Of Registration Confirmation Emailed
Oct 17, 2023
Registered-Principal Register
Sep 9, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 8, 2023
Allowed Principal Register - Sou Accepted
Sep 7, 2023
Statement Of Use Processing Complete
Aug 28, 2023
Use Amendment Filed
Sep 7, 2023
Case Assigned To Intent To Use Paralegal
Aug 28, 2023
Teas Statement Of Use Received
Feb 28, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 3, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2023
Published For Opposition
Dec 14, 2022
Notification Of Notice Of Publication E-Mailed
Nov 23, 2022
Approved For Pub - Principal Register
Nov 21, 2022
Teas/Email Correspondence Entered
Nov 21, 2022
Correspondence Received In Law Office
Nov 21, 2022
Teas Response To Office Action Received
Jul 5, 2022
Notification Of Non-Final Action E-Mailed
Jul 5, 2022
Non-Final Action E-Mailed
Jul 5, 2022
Non-Final Action Written
Jun 23, 2022
Assigned To Examiner
May 23, 2022
New Application Office Supplied Data Entered
May 20, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
